<html>
<head>PUBMED IDs for MDMX</head>
<body bgcolor='#C5F0F2'><h1>MDMX</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9926934/'>Comparative study of the p53-mdm2 and p53-MDMX interfaces.</a> February 2  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10469568/'>MDM2 and MDMX bind and stabilize the p53-related protein p73.</a> September 2  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10626796/'>Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification.</a> January 8  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10721693/'>MDM2--master regulator of the p53 tumor suppressor protein.</a> March 18  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11223036/'>MDM2 and MDMX can interact differently with ARF and members of the p53 family.</a> February 27  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11359905/'>The corepressor mSin3a interacts with the proline-rich domain of p53 and protects p53 from proteasome-mediated degradation.</a> May 22  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11528400/'>Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53.</a> August 31  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11840332/'>MDMX stability is regulated by p53-induced caspase cleavage in NIH3T3 mouse fibroblasts.</a> February 13  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/11953423/'>Mutual dependence of MDM2 and MDMX in their functional inactivation of p53.</a> April 16  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12370303/'>DNA damage induces MDMX nuclear translocation by p53-dependent and -independent mechanisms.</a> October 9  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12532331/'>The E2F-1 transcription factor is negatively regulated by its interaction with the MDMX protein.</a> January 18  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14660608/'>MDM4 (MDMX) overexpression enhances stabilization of stress-induced p53 and promotes apoptosis.</a> December 9  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15684615/'>A new twist in the feedback loop: stress-activated MDM2 destabilization is required for p53 activation.</a> February 3  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16163388/'>ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage.</a> September 16  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16511572/'>14-3-3gamma binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation.</a> March 3  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16511560/'>Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3.</a> March 3  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17018606/'>Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulators MDM2 and MDM4.</a> October 5  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17080083/'>Inactivation of the p53 pathway in retinoblastoma.</a> November 3  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17128209/'>Regulating the p53 pathway: in vitro hypotheses, in vivo veritas.</a> November 28  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17251377/'>MDMX: from bench to bedside.</a> January 26  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17369843/'>RB1 and TP53 pathways in radiation-induced sarcomas.</a> March 21  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17499002/'>MDM2 and MDM4: p53 regulators as targets in anticancer therapy.</a> May 15  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17611651/'>Gene expression profiling of metastatic brain cancer.</a> July 6  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17704807/'>Telomere attrition induces a DNA double-strand break damage signal that reactivates p53 transcription in HTLV-I leukemic cells.</a> August 21  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18045074/'>Targeting MDM2 and MDMX in retinoblastoma.</a> November 30  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18172009/'>Regulation of MDMX expression by mitogenic signaling.</a> January 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18335186/'>Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer properties.</a> March 13  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18356162/'>Phosphorylation of MDMX mediated by Akt leads to stabilization and induces 14-3-3 binding.</a> March 22  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18520179/'>Elevated MDM2 boosts the apoptotic activity of p53-MDM2 binding inhibitors by facilitating MDMX degradation.</a> June 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18520166/'>Lesions and genes: on the edge of improved isomorphic models for Alzheimer's disease?</a> June 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/20666148/'>[Study of the molecular mechanisms controlling activity of protein p53 in the development of new strategies in cancer therapeutics].</a> September 14  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20666148/'>[Study of the molecular mechanisms controlling activity of protein p53 in the development of new strategies in cancer therapeutics].</a> September 14  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19441944/'>MDM2/MDMX inhibitor peptide: WO2008106507.</a> July 28  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19521340/'>MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway.</a> August 6  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19580521/'>Stochastic modeling and simulation of the p53-MDM2/MDMX loop.</a> September 30  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19721810/'>MDM4 (MDMX) and its Transcript Variants.</a> September 2  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19897041/'>The regulation of MDM2 by multisite phosphorylation--opportunities for molecular-based intervention to target tumours?</a> August 18  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20036872/'>Bing De Ling, a Chinese herbal formula, inhibits cancer cells growth via p53.</a> July 2  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20080970/'>Identification and characterization of the first small molecule inhibitor of MDMX.</a> May 15  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20406950/'>1,25-dihydroxyvitamin D3 enhances the apoptotic activity of MDM2 antagonist nutlin-3a in acute myeloid leukemia cells expressing wild-type p53.</a> August 21  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20507307/'>MDM4 (MDMX) is overexpressed in chronic lymphocytic leukaemia (CLL) and marks a subset of p53wild-type CLL with a poor cytotoxic response to Nutlin-3.</a> September 2  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20588255/'>MDM2 recruitment of lysine methyltransferases regulates p53 transcriptional output.</a> August 27  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20810912/'>Hypoxia downregulates p53 but induces apoptosis and enhances expression of BAD in cultures of human syncytiotrophoblasts.</a> December 14  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21075910/'>A small-molecule inhibitor of MDMX activates p53 and induces apoptosis.</a> July 29  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21084273/'>An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity.</a> February 11  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21196223/'>Regulation of MDM4.</a> April 22  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21750655/'>A small-molecule p53 activator induces apoptosis through inhibiting MDMX expression in breast cancer cells.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21890637/'>Ubiquitin-specific cysteine protease 2a (USP2a) regulates the stability of Aurora-A.</a> December 28  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21910853/'>Oncogenic functions of hMDMX in in vitro transformation of primary human fibroblasts and embryonic retinoblasts.</a> February 4  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21965653/'>E3 ligases determine ubiquitination site and conjugate type by enforcing specificity on E2 enzymes.</a> February 22  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22120712/'>Abnormal MDMX degradation in tumor cells due to ARF deficiency.</a> October 17  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22370483/'>The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer.</a> September 14  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22556425/'>Hypoxia activates tumor suppressor p53 by inducing ATR-Chk1 kinase cascade-mediated phosphorylation and consequent 14-3-3Î³ inactivation of MDMX protein.</a> August 25  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22916154/'>Analysis of MDM2 and MDM4 single nucleotide polymorphisms, mRNA splicing and protein expression in retinoblastoma.</a> May 17  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22917899/'>[The new function of p53 family and its pathway related proteins in female reproduction].</a> November 7  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22917891/'>Identification of an RP1 prevalent founder mutation and related phenotype in Spanish patients with early-onset autosomal recessive retinitis.</a> February 8  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23150440/'>Identification of small molecules affecting p53-MDM2/MDMX interaction by fluorescence polarization.</a> April 30  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23836907/'>Maternal embryonic leucine zipper kinase (MELK) reduces replication stress in glioblastoma cells.</a> December 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23934659/'>Cisplatin causes cell death via TAB1 regulation of p53/MDM2/MDMX circuitry.</a> October 25  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23994448/'>Identification and expression of a novel MDM4 splice variant in human glioma.</a> June 26  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24018792/'>In vitro and in silico studies of MDM2/MDMX isoforms predict Nutlin-3A sensitivity in well/de-differentiated liposarcomas.</a> December 18  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24018773/'>Pharmacogenetics of ABC and SLC transporters in metastatic colorectal cancer patients receiving first-line FOLFIRI treatment.</a> March 13  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24018772/'>Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting.</a> March 13  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24127580/'>MDMX contains an autoinhibitory sequence element.</a> January 9  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24126697/'>Induction of p53 expression and apoptosis by a recombinant dual-target MDM2/MDMX inhibitory protein in wild-type p53 breast cancer cells.</a> July 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24190973/'>AMP-activated protein kinase induces p53 by phosphorylating MDMX and inhibiting its activity.</a> February 20  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24361594/'>DNAJB1 stabilizes MDM2 and contributes to cancer cell proliferation in a p53-dependent manner.</a> March 19  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24920214/'>Melatonin down-regulates MDM2 gene expression and enhances p53 acetylation in MCF-7 cells.</a> March 31  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25201201/'>Targeting p53-MDM2-MDMX loop for cancer therapy.</a> December 30  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25265062/'>Studying p53 family proteins in yeast: induction of autophagic cell death and modulation by interactors and small molecules.</a> February 20  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25659040/'>The alternative translated MDMX(p60) isoform regulates MDM2 activity.</a> December 15  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25670033/'>A genetic variant of MDM4 influences regulation by multiple microRNAs in prostate cancer.</a> December 15  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25809483/'>The MDM2 RING domain and central acidic domain play distinct roles in MDM2 protein homodimerization and MDM2-MDMX protein heterodimerization.</a> July 30  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25826083/'>PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesis.</a> January 30  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25974965/'>UXT, a novel MDMX-binding protein, promotes glycolysis by mitigating p53-mediated restriction of NF-ÎºB activity.</a> May 21  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26220995/'>Structure of human MDM2 complexed with RPL11 reveals the molecular basis of p53 activation.</a> October 16  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26675346/'>Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations.</a> August 9  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26867771/'>The MDM4 SNP34091 (rs4245739) C-allele is associated with increased risk of ovarian-but not endometrial cancer.</a> February 22  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26965628/'>Schedule-dependent interaction between anticancer treatments.</a> April 1  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27145840/'>The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches.</a> May 26  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27327543/'>Pharmacological activation of wild-type p53 in the therapy of leukemia.</a> June 7  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27432230/'>Platycodin D, a metabolite of Platycodin grandiflorum, inhibits highly metastatic MDA-MB-231 breast cancer growth inÂ vitro and in vivo by targeting the MDM2 oncogene.</a> March 10  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27432226/'>Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.</a> July 20  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27777309/'>Human epidermal growth factor receptor 4 (Her4) Suppresses p53 Protein via Targeting the MDMX-MDM2 Protein Complex: IMPLICATION OF A NOVEL MDMX SER-314 PHOSPHOSITE.</a> October 26  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27927748/'>AXL receptor signalling suppresses p53 in melanoma through stabilization of the MDMX-MDM2 complex.</a> December 9  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28050229/'>Dual function of MDM2 and MDMX toward the tumor suppressors p53 and RB.</a> January 5  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28482147/'>1,4,5-Trisubstituted Imidazole-Based p53-MDM2/MDMX Antagonists with Aliphatic Linkers for Conjugation with Biological Carriers.</a> May 9  2017<br></body></html>
